Suchergebnisse - "Helland, Thomas"

PubPharm (24)

1

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort

enthalten in: Clinical pharmacology and therapeutics | 2024

von Mc Laughlin, A. | Helland, T. | Klima, F. | +74

2

A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy : Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Lee, O. | Bazzi, L. | Xu, Y. | +15

3

Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ : A Randomized Clinical Trial

enthalten in: JAMA surgery | 2023

von Khan, S. | Mi, X. | Xu, Y. | +19

CommentOn: JAMA Surg. 2023 Dec 1;158(12):1274. - PMID 37870941

4

Importance of endocrine treatment adherence and persistence in breast cancer survivorship : a systematic review

enthalten in: BMC cancer | 2023

von Eliassen, F. | Blåfjelldal, V. | Helland, T. | +9

5

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review

enthalten in: BMC cancer | 2023

von Eliassen, F. | Blåfjelldal, V. | Helland, T. | +9

6

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer : a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study

enthalten in: BMJ open | 2022

von Søiland, H. | Janssen, E. | Helland, T. | +28

7

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Bertelsen, B. | Viste, K. | Helland, T. | +8

8

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites

enthalten in: Journal of personalized medicine | 2021

von Chen, Y. | Marcath, L. | Eliassen, F. | +5

9

Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

enthalten in: Molecular oncology | 2021

von Helland, T. | Naume, B. | Hustad, S. | +15

10

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

enthalten in: NPJ breast cancer | 2021

von DeCensi, A. | Johansson, H. | Helland, T. | +15